Home/Filings/4/0001209191-24-004953
4//SEC Filing

Ropp Sam 4

Accession 0001209191-24-004953

CIK 0001850906other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 5:49 PM ET

Size

7.3 KB

Accession

0001209191-24-004953

Insider Transaction Report

Form 4
Period: 2024-03-15
Ropp Sam
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-15+4,18716,750 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-154,18750,250 total
    Common Stock (4,187 underlying)
Footnotes (3)
  • [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.

Issuer

Singular Genomics Systems, Inc.

CIK 0001850906

Entity typeother

Related Parties

1
  • filerCIK 0001973313

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:49 PM ET
Size
7.3 KB